Put Options

2 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2021

Jan 18, 2022

SELL
$4.5 - $11.91 $45,000 - $119,100
-10,000 Reduced 61.35%
6,300 $28,000
Q3 2021

Oct 26, 2021

BUY
$8.52 - $24.77 $138,876 - $403,751
16,300 New
16,300 $95,000

Others Institutions Holding NRXP

# of Institutions
2
Shares Held
17.4K
Call Options Held
0
Put Options Held
0

About NRX Pharmaceuticals, Inc.


  • Ticker NRXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,641,296
  • Market Cap $81.8M
  • Description
  • NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-10...
More about NRXP
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.